Assessment of Potential Interactions Between Cocaine and Tolcapone - 1
This trial is active, not recruiting.
|Sponsor||National Institute on Drug Abuse (NIDA)|
|Start date||July 2001|
|End date||March 2002|
|Trial size||16 participants|
|Trial identifier||NCT00033059, NCT00024765, NIDA-CTO-0003-1|
The purpose of this study is to assess the potential interactions between intravenous (IV) cocaine and tolcapone.
Male or female participants from 18 years up to 45 years old.
Inclusion Criteria: Volunteers dependent on cocaine and are non-treatment seeking; between 18-45 yrs of age; DSM-4 criteria for cocaine abuse or dependence Exclusion Criteria: Additional criteria available during screening at the site
|Official title||Assessment of Potential Interactions Between Intravenous Cocaine and Tolcapone|
|Principal investigator||Thomas Newton, M.D.|
|Description||Double-blind, inpatient study by screening responses to cocaine infusions of 20 and 40 mg i.v. subjects into 1 of 2 treatment groups to assess potential interactions between i.v. cocaine infusion and treatment with tolcapone.|
Call for more information